SLAMF7 anticorps (AA 249-335)
Aperçu rapide pour SLAMF7 anticorps (AA 249-335) (ABIN7872814)
Antigène
Voir toutes SLAMF7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- AA 249-335
-
Fonction
- SLAMF7 Antibody / CS1 (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogène
- A portion of amino acids 249-335 from the human protein was used as the immunogen for the SLAMF7 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the SLAMF7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store the SLAMF7 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- SLAMF7 (SLAM Family Member 7 (SLAMF7))
-
Autre désignation
- SLAMF7
-
Sujet
- CS1, also known as novel Ly9, SLAMF7, 19A24 or CRACC, is a homophilic cell surface receptor. It is a member of the SLAM (signaling lymphocytic activation molecule) family of receptors expressed on natural killer (NK) cells, T cells and stimulated B cells. CS1 contains immunoreceptor tyrosine-based switch motifs in its cytoplasmic domain but, unlike other SLAM receptors, it does not recruit SAP (SLAM-associated protein). In humans, CS1 activates NK cells through an EAT-2-mediated pathway that is SAP-independent. CS1 recruits and associates with EAT-2, a protein closely related to SAP. EAT-2 induces phosphorylation of CS1 which then, upon ligand binding, activates downstream cytotoxicity effectors PLC and PI 3K. In mice, the EAT-2 association with CS1 has an inhibitory effect on the activation of NK cells.
-
UniProt
- Q9NQ25
Antigène
-